|
Czech Republic Refuses Baxter Swine Flu Vaccine On Safety
Grounds
Health officials admit fast tracked shots could cause
deaths
|
|
|
Government health officials in the Czech Republic have refused
to buy H1N1 flu vaccines from US pharmaceutical firm Baxter
International, citing safety concerns.
According to a report by the Czech
News Agency CTK, one of the largest English language
news outlets in the country, the Czech Health Ministry has halted
talks with Baxter citing "the firm's inability to guarantee
that the vaccine is safe and who will bear the risks for possible
side-effects."
The country plans to buy vaccines to cover 25
percent of its population of ten million, but has said it will
not buy swine flu vaccine from Baxter before it has acquired
a European registration.
"It is a pity, but, unfortunately, at the
moment when we accepted the bids, Baxter was unable to confirm
that it will deliver a registered vaccine," Health Minister
Dana Juraskova said.
Instead, the country will likely buy its supplies
from Novartis and GlaxoSmithKline, but only after the vaccines
have undergone regular clinical tests and gained European Medicines
Agency registration.
In another CTK
report, Deputy Health minister Marek Snajdr was
quoted as saying the vaccine "may have side effects and
it may even cause death if used".
Confirmed cases of H1N1 flu in the country remain
below 150, according to all estimates, and no one has died from
the virus.
(Article continues below)
As we have previously noted, Baxter has a very
recent and most disturbing connection to flu vaccines and the
Czech Republic.
As reported by multiple sources last March, including the Times
of India, vaccines contaminated with deadly live
H5N1 avian flu virus were distributed to 18 countries in December
2008 by a lab at an Austrian branch of Baxter.
It was only by providence that the batch was first tested on
ferrets in the Czech Republic, before being shipped out for
injection into humans. The ferrets all died and the shocking
discovery was made.
Czech newspapers
immediately questioned whether the events were
part of a conspiracy to deliberately provoke a pandemic, following
up on accusations already made by
health officials in other countries.
Initially, Baxter attempted to stonewall questions by invoking
“trade secrets” and refused to reveal how the vaccines
were contaminated with H5N1. After increased pressure they then
claimed that pure H5N1 batches were sent by accident.
Since the probability of mixing a live virus biological weapon
with vaccine material by accident is
virtually impossible, this leaves no other explanation
than that the contamination was a deliberate attempt to weaponize
the H5N1 virus to its most potent extreme and distribute it
via conventional flu vaccines to the population who would then
infect others to a devastating degree as the disease went airborne.
The fact that Baxter mixed the deadly H5N1 virus with a mix
of H3N2 seasonal flu viruses is the smoking gun. The H5N1 virus
on its own has killed hundreds of people, but it is less airborne
and more restricted in the ease with which it can spread. However,
when combined with seasonal flu viruses, which as everyone knows
are super-airborne and easily spread, the effect is a potent,
super-airbone, super deadly biological weapon.
Indeed, some
have already suggested that the current swine flu
scare could represent the use of such a weapon.
In a separate case, an ongoing lawsuit has charged that Baxter
intentionally
used untested and dangerous ingredients in some
of its vaccines in order to increase profits.
WHO officials are reportedly still closely monitoring ongoing
investigations into Baxter's contaminated vaccines, despite
this the company is leading the way in the production of swine
flu vaccines that could
become mandatory. Indeed, in an well timed act
of clairvoyancy, Baxter filed its swine flu vaccine patent exactly
one
year ahead of the outbreak.
The company announced
last week that it had completed its first commercial
batches of H1N1 vaccine in late July and is now in talks with
national health authorities worldwide. The company has initiated
a European Medicines Agency license application for the vaccine,
but it has not yet been approved.
Baxter says it will provide a total of 80 million
doses for 40 million people in five countries including the
UK, Ireland and New Zealand.
The US will not take the Baxter-made vaccine
as it has not received Food and Drug Administration approval.
In addition to regulators in Europe and the US
planning to fast-track the approval of swine flu vaccines, new
regulations have been put in place to provide pharmaceutical
companies with blanket immunity from lawsuits.
"Vaccine makers and federal officials will
be immune from lawsuits that result from any new swine flu vaccine,
under a document signed by Secretary of Health and Human Services
Kathleen Sebelius," reported
the Associated Press last month.
Mass vaccination will probably start at the end
of November and in early December. Early reports indicate that
health officials in the UK and the US are planning
to set up clinics within every school in both countries.
----------------------------------------------------------------------------------------------------------------------
Alex
Jones LIVE, A Fourth Hour Of Streaming TV Now Added To The Infowars
Radio Show
Click here to get your subscription today!
----------------------------------------------------------------------------------------------------------------------
|
INFOWARS:
BECAUSE THERE'S A WAR ON FOR YOUR MIND
|
|
